GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management
Progress is tracked through a combination of weight measurements, body composition analysis such as InBody scans, and ongoing evaluations of how your body is responding to treatment
Learn more about our weight loss program Vanessa Buie, MD, MBA Vanessa Buie, MD, MBA, is an expert minimally invasive gastrointestinal and bariatric surgeon who specializes in primary and revisional weight loss surgery, and is highly skilled in all surgical techniques for hernia repair
Nausea, appetite reduction, and fatigue can occur with GLP-1 therapy and may be confused with thyroid dysregulation
What many people dont realize is that mitochondria also depend on essential nutrients to do their job